ONESOURCE2024-07-012024-09-30 ONESOURCE2024-07-012024-09-30 ONESOURCE2024-07-012024-09-30in-bse-fin:OneOperatingExpenses01Member ONESOURCE2024-07-012024-09-30in-bse-fin:FourOperatingExpenses01Member ONESOURCE2024-09-30 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 544292 ONESOURCE NOTLISTED Onesource Specialty Pharma Limited Equity 2024-04-01 2025-03-31 2024-10-23 2024-10-15 INR Millions Half yearly 18:15:00 19:15:00 2024-10-23 2024-10-23 true Cash Flow Indirect Not applicable Single segment Pharma 2024-07-01 2024-09-30 Unaudited Consolidated 679800000.00 5820000.00 685620000.00 123090000.00 0.00 0.00 227760000.00 207260000.00 190610000.00 327720000.00 1076440000.00 -390820000.00 0.00 -390820000.00 0.00 0.00 0.00 0.00 -390820000.00 0.00 0.00 0.00 -2430000.00 -393250000.00 490000.00 -392760000.00 0.00 0.00 0.00 0.00 41550000.00 1 -9.41 -9.41 -9.41 -9.41 -18.82 -18.82 0.02 0.00 -0.01 1. In terms of Regulation 52 and Regulation 54 of SEBI ( Listing Obligation and Disclosure Requirements ) regulations 2015, ( Listing Requirements ), as amended, the Statement of Unaudited Standalone Financial Results for the quarter and six months ended 30 September 2024 ( Statement ) of OneSource Specialty Pharma Limited (formerly known as Stelis Biopharma Limited) ('the Parent' or 'the Company') has been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on 23 October 2024. The aforesaid results for the quarter and six months ended 30 September 2024 has been reviewed by Deloitte Haskins & Sells, the statutory auditors of the Company. The statutory auditors of the Company have issued an unmodified conclusion in respect of the limited review for the quarterand six months ended 30 September 2024. 2. The Company had entered into the Scheme of arrangement whereby the Company, will set up ‘One Source’, Specialty Pharma CDMO that will be established through the demerger of CDMO unit of Steriscience Specialities Private Limited ('Steriscience') and Oral Soft Gelatin technologies of Strides Pharma Science Limited ('Strides'). Pursuant to the approval by the Hon'ble tribunal, the shares of the Company are listed on the Exchanges. 3.The results displayed here are as furnished by the company at the relevant point of time. 4. Due to technical issue the negetive amount of Exchange differences in translating the financial statements of foreign operations has been showed under the head Share of Profit/ loss of associates and joint venture accounted for using equity method instead of Other comprehensive income Single segment 2024-04-01 2024-09-30 Unaudited Consolidated 1463700000.00 17890000.00 1481590000.00 351420000.00 0.00 0.00 457010000.00 411230000.00 381210000.00 599850000.00 2200720000.00 -719130000.00 0.00 -719130000.00 0.00 0.00 0.00 0.00 -719130000.00 0.00 0.00 0.00 -2360000.00 -721490000.00 490000.00 -721000000.00 0.00 0.00 0.00 0.00 40910000.00 1 -17.31 -17.31 -17.31 -17.31 -34.62 -34.62 0.02 0.00 -0.01 other expenses 327720000.00 other expenses 599850000.00 6536060000.00 432990000.00 0.00 0.00 1731410000.00 1452900000.00 0.00 0.00 37910000.00 0.00 281780000.00 319690000.00 0.00 773860000.00 11246910000.00 137770000.00 71580000.00 634030000.00 87310000.00 245630000.00 0.00 50000000.00 1088550000.00 354930000.00 1581250000.00 0.00 0.00 12828160000.00 41550000.00 4007780000.00 4049330000.00 4049330000.00 4534710000.00 0.00 79570000.00 4614280000.00 26230000.00 0.00 4640510000.00 1501550000.00 537200000.00 1205670000.00 3244420000.00 849910000.00 43990000.00 0.00 4138320000.00 8778830000.00 12828160000.00 411230000.00 -25460000.00 -322380000.00 0.00 -121110000.00 0.00 0.00 0.00 0.00 -268320000.00 0.00 -142200000.00 0.00 381210000.00 0.00 0.00 0.00 0.00 0.00 -4710000.00 0.00 0.00 10360000.00 0.00 0.00 0.00 -2030000.00 0.00 0.00 -83410000.00 -802540000.00 0.00 0.00 -5350000.00 0.00 0.00 -807890000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 300300000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 255260000.00 249990000.00 0.00 0.00 0.00 0.00 0.00 5350000.00 0.00 292930000.00 0.00 3250000.00 0.00 0.00 802840000.00 2000000000.00 0.00 1345200000.00 0.00 0.00 970000000.00 1156170000.00 0.00 0.00 0.00 410220000.00 0.00 -7440000.00 853810000.00 49170000.00 0.00 49170000.00 109720000.00 158890000.00 490000.00 490000.00 0.00 0.00